fashion -WSS

fashion

author：fashion 2025-10-02 13:01:19 - browse：8858

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Covid vaccine financial winners and losers, from Pfizer to Novavax

knowledge

WSS

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Decaf coffee targeted by food safety group under obscure FDA rule

PBM reforms clear House panel

Morphosys mixed study results for blood cancer drug

FDA's Woodcock to retire early next year

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

focus

fashion

leisure time

Continuity nursing helped my family in our darkest PICU moments

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Tori Bowie and the unacceptable rates of Black maternal death

Weight loss drug costs may need more research, senator suggests

Sports medicine is finally prioritizing gender equality

Morphosys mixed study results for blood cancer drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Weight loss drug costs may need more research, senator suggests

The high cost of giving birth even with insurance

Oprah kicked off a national conversation on obesity. Let's have it

hotspot

FDA's Woodcock to retire early next year

Washington mulls new rules to avert another Change Healthcare

There's no autism epidemic. It's an autism diagnosis epidemic

Congress must reauthorize a committee to support older Americans

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Surge of respiratory disease in China has likely explanation

hotspot

knowledge

hotspot

hotspot